articleNano TodayDec 1, 2011HYBRID OA

Toxicology and clinical potential of nanoparticles

London Centre for Nanotechnology · University College London · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

In recent years, nanoparticles (NPs) have increasingly found practical applications in technology, research and medicine. The small particle size coupled to their unique chemical and physical properties is thought to underlie their exploitable biomedical activities. Here, we review current toxicity studies of NPs with clinical potential. Mechanisms of cytotoxicity are discussed and the problem of extrapolating knowledge gained from cell-based studies into a human scenario is highlighted. The so-called 'proof-of-principle' approach, whereby ultra-high NP concentrations are used to ensure cytotoxicity, is evaluated on the basis of two considerations; firstly, from a scientific perspective, the concentrations…

No related works found for this paper.